Sanofi Clinches Key Phase III Immunology Win With Rilzabrutinib

Prior Late-Stage Readout In Pemphigus Was A Setback

 
• By Mandy Jackson
Winner as style of life. Horizontal shot of young beautiful woman in sports clothing keeping arms raised and smiling while passing finish line during jogging.
Sanofi may have the first BTK inhibitor approved for ITP • Source: Shutterstock

More from Clinical Trials

More from R&D